Related Experiment Video
Updated: Jun 22, 2026
09:37
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Cluster headache and Alpha 1-antitrypsin deficiency.
O Summ1, N Gregor, M Marziniak
1Department of Neurology, University of Münster, Münster, Germany. oliver.summ@ucsf.edu
Cephalalgia : an International Journal of Headache
|June 12, 2009
Summary
This study found that specific alpha 1-antitrypsin (alpha(1)-AT) gene variants (S or Z alleles) are linked to increased cluster headache (CH) attack frequency, offering new insights into CH pathophysiology.
Area of Science:
- Genetics
- Neurology
- Pulmonology
Background:
- Cluster headache (CH) is a severe primary headache disorder with poorly understood pathophysiology.
- Associations between CH and lung diseases, smoking, and sleep apnea have been noted.
- Specific alpha 1-antitrypsin (alpha(1)-AT) genotypes are risk factors for emphysema.
Purpose of the Study:
- To investigate the association between common SERPINA1 gene genotypes and cluster headache.
- To explore the relationship between alpha(1)-AT levels and CH characteristics.
Main Methods:
- Genotyping and serum alpha(1)-AT level analysis in 55 CH patients and 55 controls.
- Documentation of CH patient characteristics, including attack frequency.
- Comparison of genotype frequencies and alpha(1)-AT levels between patients and controls.
Main Results:
- No association was found between CH and genotypes other than the homozygous wild type for alpha(1)-AT.
- A significant difference in CH attack frequency was observed in patients carrying heterozygous or homozygous M alleles.
- The presence of S or Z alleles in the SERPINA1 gene was associated with a higher CH attack frequency.
Conclusions:
- The study suggests a potential genetic link between SERPINA1 gene variants and cluster headache severity.
- Alpha-1 antitrypsin (alpha(1)-AT) S or Z alleles may influence the frequency of cluster headache attacks.
- Further research is warranted to elucidate the role of alpha(1)-AT in CH pathophysiology.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...